Daruma Capital Management Lowered By $1.62 Million Its Osi Systems (OSIS) Position; ENTEST BIOMEDICAL (ENTB) Shorts Increased By 39.22%

November 14, 2017 - By Winifred Garcia

ENTEST BIOMEDICAL INCORPORATED (OTCMKTS:ENTB) had an increase of 39.22% in short interest. ENTB’s SI was 7,100 shares in November as released by FINRA. Its up 39.22% from 5,100 shares previously. With

34,200 avg volume, 0 days are for ENTEST BIOMEDICAL INCORPORATED (OTCMKTS:ENTB)’s short sellers to cover ENTB’s short positions. It closed at $0.0294 lastly. It is down 0.00% since November 14, 2016 and is . It has underperformed by 16.70% the S&P500.

Daruma Capital Management Llc decreased Osi Systems Inc (OSIS) stake by 3.14% reported in 2017Q2 SEC filing. Daruma Capital Management Llc sold 21,653 shares as Osi Systems Inc (OSIS)’s stock declined 0.45%. The Daruma Capital Management Llc holds 667,428 shares with $50.16 million value, down from 689,081 last quarter. Osi Systems Inc now has $1.72 billion valuation. It closed at $90.7 lastly. It is down 56.65% since November 14, 2016 and is uptrending. It has outperformed by 39.95% the S&P500.

Entest BioMedical, Inc. is engaged in the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The company has market cap of $1.30 million. The Firm is engaged in the development and commercialization of ImenVax, a therapeutic cancer vaccine for use in canines, and the development and commercialization of certain intellectual property for non-human veterinary therapeutic use. It currently has negative earnings. The Company’s products include ImenVax I, ImenVax II, ImenVax III and ENT-576.

Among 9 analysts covering OSI Systems (NASDAQ:OSIS), 8 have Buy rating, 1 Sell and 0 Hold. Therefore 89% are positive. OSI Systems had 25 analyst reports since August 25, 2015 according to SRatingsIntel. As per Friday, July 7, the company rating was maintained by Jefferies. Roth Capital maintained OSI Systems, Inc. (NASDAQ:OSIS) rating on Tuesday, August 29. Roth Capital has “Buy” rating and $97.0 target. The stock of OSI Systems, Inc. (NASDAQ:OSIS) earned “Buy” rating by Drexel Hamilton on Wednesday, November 16. Sidoti initiated the stock with “Buy” rating in Wednesday, September 16 report. B. Riley & Co maintained it with “Buy” rating and $92 target in Friday, August 25 report. The stock of OSI Systems, Inc. (NASDAQ:OSIS) has “Buy” rating given on Friday, October 30 by Roth Capital. The firm earned “Buy” rating on Friday, February 19 by B. Riley & Co. On Tuesday, August 25 the stock rating was maintained by Roth Capital with “Buy”. The company was maintained on Tuesday, October 13 by Benchmark. The stock of OSI Systems, Inc. (NASDAQ:OSIS) earned “Buy” rating by Jefferies on Friday, August 25.

Daruma Capital Management Llc increased Orasure Technologies Inc (NASDAQ:OSUR) stake by 2.72M shares to 2.82M valued at $48.70M in 2017Q2. It also upped Innophos Holdings Inc (NASDAQ:IPHS) stake by 158,861 shares and now owns 1.18 million shares. Newpark Res Inc (NYSE:NR) was raised too.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>